University of Windsor

Scholarship at UWindsor
Electronic Theses and Dissertations

Theses, Dissertations, and Major Papers

2009

Characterization of the Sak kinase interaction with cyclin B1 and
Gadd45a
Bing Wu
University of Windsor

Follow this and additional works at: https://scholar.uwindsor.ca/etd

Recommended Citation
Wu, Bing, "Characterization of the Sak kinase interaction with cyclin B1 and Gadd45a" (2009). Electronic
Theses and Dissertations. 8113.
https://scholar.uwindsor.ca/etd/8113

This online database contains the full-text of PhD dissertations and Masters’ theses of University of Windsor
students from 1954 forward. These documents are made available for personal study and research purposes only,
in accordance with the Canadian Copyright Act and the Creative Commons license—CC BY-NC-ND (Attribution,
Non-Commercial, No Derivative Works). Under this license, works must always be attributed to the copyright holder
(original author), cannot be used for any commercial purposes, and may not be altered. Any other use would
require the permission of the copyright holder. Students may inquire about withdrawing their dissertation and/or
thesis from this database. For additional inquiries, please contact the repository administrator via email
(scholarship@uwindsor.ca) or by telephone at 519-253-3000ext. 3208.

NOTE TO USERS

This reproduction is the best copy available.

UMI'

Characterization of the Sak kinase interaction with Cyclin Bl and
Gadd45a
by

Bing Wu

A Thesis
Submitted to the Faculty of Graduate Studies
through Biological Sciences
in Partial Fulfillment of the Requirements for
the Degree of Master of Science at the
University of Windsor

Windsor, Ontario, Canada

2009

©2009 Bing Wu

1*1

Library and Archives
Canada

Bibliotheque et
Archives Canada

Published Heritage
Branch

Direction du
Patrimoine de I'edition

395 Wellington Street
OttawaONK1A0N4
Canada

395, rue Wellington
OttawaONK1A0N4
Canada
Your file Votre reference
ISBN: 978-0-494-57584-0
Our file Notre reference
ISBN: 978-0-494-57584-0

NOTICE:

AVIS:

The author has granted a nonexclusive license allowing Library and
Archives Canada to reproduce,
publish, archive, preserve, conserve,
communicate to the public by
telecommunication or on the Internet,
loan, distribute and sell theses
worldwide, for commercial or noncommercial purposes, in microform,
paper, electronic and/or any other
formats.

L'auteur a accorde une licence non exclusive
permettant a la Bibliotheque et Archives
Canada de reproduire, publier, archiver,
sauvegarder, conserver, transmettre au public
par telecommunication ou par I'lnternet, preter,
distribuer et vendre des theses partout dans le
monde, a des fins commerciales ou autres, sur
support microforme, papier, electronique et/ou
autres formats.

The author retains copyright
ownership and moral rights in this
thesis. Neither the thesis nor
substantial extracts from it may be
printed or otherwise reproduced
without the author's permission.

L'auteur conserve la propriete du droit d'auteur
et des droits moraux qui protege cette these. Ni
la these ni des extraits substantiels de celle-ci
ne doivent etre imprimes ou autrement
reproduits sans son autorisation.

In compliance with the Canadian
Privacy Act some supporting forms
may have been removed from this
thesis.

Conformement a la loi canadienne sur la
protection de la vie privee, quelques
formulaires secondaires ont ete enleves de
cette these.

While these forms may be included
in the document page count, their
removal does not represent any loss
of content from the thesis.

Bien que ces formulaires aient inclus dans
la pagination, il n'y aura aucun contenu
manquant.

1+1

Canada

Author's Declaration of Originality

I hereby certify that I am the sole author of this thesis and that no part of this
thesis has been published or submitted for publication.
I certify that, to the best of my knowledge, my thesis does not infringe upon
anyone's copyright nor violate any proprietary rights and that any ideas, techniques,
quotations, or any other material from the work of other people included in my thesis,
published or otherwise, are fully acknowledged in accordance with the standard
referencing practices. Furthermore, to the extent that I have included copyrighted
material that surpasses the bounds of fair dealing within the meaning of the Canada
Copyright Act, I certify that I have obtained a written permission from the copyright
owner(s) to include such material(s) in my thesis and have included copies of such
copyright clearances to my appendix.
I declare that this is a true copy of my thesis, including any final revisions, as
approved by my thesis committee and the Graduate Studies office, and that this thesis has
not been submitted for a higher degree to any other University of Institution.

111

ABSTRACT

The Polo like kinase (Plk) family members are critical regulators of cell cycle
progression, mitosis, cytokinesis and the DNA damage response. While much is known
regarding the phenotype associated with loss or overexpression of Sak, less than a
handful of interacting partners/substrates are known. Therefore, the identification and
characterization of Sak interacting partners will contribute to our understanding of the
essential role of Sak in the cell.
Our results show that Sak physically interacts with and co-localizes with Cyclin
Bl. Furthermore, we identified Gadd45a as both an interacting partner and a substrate for
Sak. The site of phosphorylation was putatively identified as TyrlSl on Gadd45a. In
addition, we found that endogenous Sak protein levels are decreased in response to UV
and that this decrease is p53-dependent. These findings suggest that Sak in addition to
Sak playing a role in centrosome duplication that it may also function in mitotic entry and
DNA damage response pathways.
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CHAPTER I
INTRODUCTION

Polo-like Family Function and Members
The polo-like kinases (Plks) are a conserved subfamily of Ser/Thr protein
kinases that play pivotal roles in regulating various cellular and biochemical events at
multiple stages of cell cycle progression (Glover et al, 1998; Nigg, 1998; Dai et al,
2003). They regulate cell cycle progression, including centrosome duplication, DNA
damage response in S phase, Golgi dynamics in G2 phase as well as Mitotic entry,
spindle assembly and cytokinesis in M phase.
The founding member of this family, Polo, was originally identified in the
fruit fly {Drosophila melanogaster) and was shown to be a serine-threonine kinase
that is required for mitosis (Fenton and Glover, 1993). Lower eukaryotic organisms
such as the budding yeast Saccharomyces

cerevisiae and the fission yeast

Schizosaccharomyces pombe have only one homolog of Polo, Cdc5 and Plol,
respectively (Kitada et al, 1993; Ohkura et al, 1995). Higher eukaryotic organisms
such as the Caenorhabditis elegans contains three Polo structural homologues (Plkl,
Plk2 and Plk3) (Ouyang et al, 1999; Chase et al, 2000), while vertebrates have four
Plk family members (Plkl, Plk2, Plk3 and Plk4/Sak) (Glover et al, 1998; Nigg,
1998). The increase in number of Plk members in higher organisms is likely a
reflection for the need of tighter controls on the cell cycle regulation.

The Structure of the Polo-like Kinases
All Plks share two conserved features: first, a Ser/Thr kinase domain in the
amino-terminal region of these proteins which is critical for the various cellular
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functions of the Plks; second a structural motif termed the Polo box domain (PBD) in
the noncatalytic carboxyl-terminal region (Li et al, 1996; Elia et al, 2003a). The
PBD plays important roles in both Plk localization and function. Mutation of the PBD
of Plkl results in loss of Plkl localization to the spindle pole and the bud neck.
Recent studies have also revealed that the PBD functions as a docking site for various
serine/threonine phosphorylated proteins (Elia et al, 2003b; Lowery et al, 2004). The
phosphopeptide-binding function of the PBD is intricately linked to how Plkl
controls cell cycle progression through mitosis. Plks 1-3 share a common domain
architecture consisting of an N-terminal kinase domain and two polo box domains at
C-terminus. Sak/Plk4 differs from other polo-like kinases in that it has only a single
polo box at C-terminus (Hudson et al. 2001; Leung et al. 2002; Swallow et al, 2005).
This chapter mainly introduces the polo-like kinases in lower eukaryotes and
Plk 1-3, Sak that is the main focus in our lab will be discussed in detail at chapter 2.
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Figure 1. Polo-like kinase structure. Plkl-3 contain an amino-terminal kinase
domain and two carboxy-terminal PBD. Sak/Plk4 differs from other polo-like
kinases in that it has only a single polo box at the carboxy-termimis, while all
other Plks have two. The kinase domain is represented by the yellow colour and
the polo-box domains are showed in green colour.
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Plks Expression and Kinase Activity
The Plk gene family are differentially expressed during normal cell cycle
progression. In general, Plkl expression/activity is low in GO, Gl, and S, begins to
increase in G2, and peaks in M phase (Roshak et al, 2000; Alvarez et al, 2001;
Anger et al, 2003). Plk2 mRNA and protein is expressed in early Gl, has a fast
turnover rate (half-life of B15 min) and is catalytically active (Ma et al, 2003b). This
finding is consistent with the function of Plk2 as a regulator of Gl progression in
mammalian cells (Ma et al, 2003a).The precise role of Plk3 in mammalian cells is
not yet fully established, but it appears to be primarily involved in pathways involved
in the cellular response to DNA damage (Barr et al., 2004). Maximum levels of Plk3
mRNA expression are detected 1 h after FGF or serum stimulation of quiescent NTH
3T3 cells, and expression decreases to basal levels by 8 h (Donohue et al, 1995).
However, Plk3 protein levels remain relatively constant in mitogen stimulated NIH
3T3 cells (Chase et al, 1998; Bahassi et al, 2002)
The Plk family genes are also differentially regulated in stressed cells; for
example, when DNA-damaging agents are added to cycling cells, Plkl expression
decreases, but Plk2 and Plk3 expression increases. Furthermore, Plkl is expressed at
the highest levels in tissues with actively proliferating cell populations; for example,
the placenta (Wolfe/ al, 2000), spleen (Golsteyn et al, 1994), ovary (Takai et al,
1999), and testis (Syed and Hecht, 1998). Plkl transcripts are either undetectable or
present at very low levels in most other adult tissues, including the liver, kidney, brain
and skin (Wolf e? al, 2000). The tissue distribution of Plk2 and Plk3 differ greatly
from Plkl. Plk2 and Plk3 transcripts have a broad tissue distribution. Finally, Plkl, 2,
3 are expressed to varying degrees in different human tissue types and it has been
reported that Plkl expression is increased and Plk3 expression is decreased in tumor
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specimens. Plk2 gene expression levels in human tumor specimens have not yet been
reported (Winkles JA et al., 2005).
The differential regulation of Plk family member gene expression indicates
one cellular strategy for controlling Plk activity in mammalian cells.

Plk Localization
The localization of individual Plks is dynamically regulated during the cell
cycle. Plk proteins from yeast to mammalian undergo apparent

subcellular

localization differences. In unicellular organisms such as yeasts, the Plks (Cdc5 and
Plol) localize to the spindle pole bodies (SPBs) but with apparent differences in
timing. Cdc5 localizes to the SPBs (Shirayama et al, 1998; Song et al.,2000) during
early Gl and remains there until late mitosis, whereas Plol associates with the SPBs
after the activation of Cdc2 (Cdkl) and dissociates from the SPBs as Cdc2 becomes
inactive (Mulvihill et al, 1999). In addition, Cdc5 localizes to the septin ring
filaments in G2 and remains until late mitosis (Sakchaisri et al, 2004), whereas Plol
localizes to the medial ring structures at the time of their formation (Bahler et al,
1998). The founding member of this family, Drosophila

polo is present in

centrosomes early in mitosis, accumulates around the nuclear envelope until its
breakdown. During prometaphase, polo localizes to the kinetochores and at metaphase
associates to spindle microtubules (Moutinho-Santos et al., 1999).
Studies in cultured mammalian cells revealed that Plkl localizes to the
cytoplasm and the nucleus during G2 and is specifically targeted to the centrosomes
(Taniguchi E., 2002). During early mitosis, Plkl can be found at centrosomes and
kinetochores (Golsteyn RM et al, 1995). In addition, a fraction of Plkl translocates to
the midzone/midbody late in mitosis. Plk2 localizes to the centrosome, indicating a
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role for Plk2 in centriloe duplication (Warnke et al, 2004). There are several
conflicting reports about Plk3 localization in the literature. Plk3 has been reported to
colocalize with the centrosome, the spindle pole and spindle microtubules (Wang Q et
al.,), as well as with the Golgi apparatus (Ruan Q et al, 2004), and actin-containing
plaques (Holtrich U et al, 1995, Wendy C et al. 2007) demonstrated that Plk3
localizes in the nucleolus.
The dynamic subcellular localization of Plk homologs suggests the functional
complexity of these enzymes in various organisms. The apparent localization
differences between yeast and mammalian Plks may reflect differences in the spatial
and temporal regulation of the mitotic and cytokinetic machineries that these
organisms utilize and the inherent need for greater controls in multicellular organisms.

The Biological Functions of Plks
Polo-like kinases play critical roles during multiple stages of cell cycle
progression, they are important regulators for many cellular events critical for cell
division including centrosome duplication and maturation, DNA damage checkpoint
activation, mitotic onset, bipolar spindle formation, Golgi fragmentation and
assembly, chromosome segregation, and cytokinesis. This review will focus on the
roles of Plks in mitotic entry, mitotic exit and cytokinesis.
i) Mitotic Entry
In eukaryotic cells, initiation of mitosis requires nuclear translocation and
activation of M-phase promoting factor (MPF); the complex of a Cyclin-dependent
kinase Cdkl and the Cyclin B (Nurse, 1990; Hunt, 1991). Cyclin B accumulation,
phosphorylation of Cdkl and intracellular localization of Cyclin Bl is regulated
during the progression of the cell cycle (Pines, 1999; Yang and Kornbluth, 1999).
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During S and G2 phases, Cyclin B accumulates and binds to Cdkl to form
heterodimers. Cyclin B facilitates the inhibitory phosphorylation of Cdkl at Thrl4
and Tyrl5, which are catalyzed by Weel, Mikl and Mytl kinases. At the end of G2,
abrupt dephosphorylation of these sites by Cdc25 activates Cyclin B / Cdkl complex
(Morgan, 1995; Nigg, 2001) which triggers mitotic entry. Recent studies have shown
that Plkl acts as an important coordinator for MPF activation. Plkl promotes mitotic
entry by activating Cyclin B/Cdkl at three different levels. (1) Plkl phosphorylates
one member

of the Cdc25

family

of phosphatases, Cdc25C. Cdc25C is

phosphorylated by Plkl in a nuclear export signal sequence during G2-M phase and
this phosphorylation is necessary for the nuclear translocation and activation of
Cdc25C during prophase.( Roshal AK et al, 2000; Toyoshima-Morimoto et al, 2002)
Nuclear Cdc25C plays a role in keeping nuclear MPF active by counteracting the
inhibitory activity of Weel, which is constitutively nuclear. (2) At the same time,
Plkl phosphorylates the Cyclin B/Cdkl-inhibiting kinase Weel and Mytl (Watanabe
N et al, 2004; Nakajima H et al, 2003), leading to enhanced association with the
SCF/beta-TrCP E3 ubiquitin ligase, thereby inducing its degradation. (3) In addition
to, it has been shown that Plkl phosphorylates Cyclin Bl at centrosomes, the first site
at which CyclinB/Cdkl is activated and the phosphorylation triggers Cyclin Bl
nuclear translocation during prophase (Toyoshima-Morimoto et al, 2001). During S
and G2 phases, Cyclin Bl localized to the cytoplasm, where a subpopulation
associated with microtubules. In late G2 phase, a fraction of CyclinBl was bound to
the centrosomes, and at prophase, Cyclin Bl translocates into the nucleus. The
nuclear accumulation of Cyclin Bl during prophase is thought to be important for
initiating and coordinating M-phase events in vertebrate cells (Pines, 1999; Yang and
Kornbluth, 1999; Takizawa and Morgan, 2000).
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In Xenopus, Polo-like kinase Plxl plays an important role in initiating the
G2/M transition. Data from the Xenopus system indicate that Plxl phosphorylates
Cyclin Bl on Ser 101, This is supported by data indicating that Plkl phosphorylates
Cyclin Bl on Ser 133 in human cells and Ser 147 in mammalian cells (Jackman et al,
2003). This phosphorylation of Cyclin Bl initially occurs on centrosomes in
prophase, and the phosphorylation does not cause Cyclin Bl to move into the nucleus
(Jackman et al, 2003). It has been proposed that phosphorylated Cyclin Bl facilitates
the interaction between Cdkl and Cdc25C (Peter et al, 2002). In this case,
centrosomes may function as sites of integration for the proteins that trigger mitosis
(Jackman et al, 2003). Furthermore, the studies carried out in Xenopus egg extracts
and oocytes show that Plxl is the initial phosphorylating and activating kinase for
Cdc25C in vivo and the activation of Cdkl/Cyclin B also requires the activation of
Plxl as a trigger kinase to initiate Cdc25C activation (Qian et al, 1998a, 2001). In
addition, Plxl and Cyclin B/Cdkl may act in a positive feedback loop ensuring
complete activation of Cyclin B/Cdkl and mitotic entry (Alrieu A et al, 1998).
Plk2 doesn't appear to play a role mitotic entry, it is identified as an earlygrowth-response gene. Plk2 may primarily function as a regulator of Gl and early S
phase progression, a time when both Plk2 mRNA and protein levels peak (Simmons
DL etal, 1992; Ma S et al, 2003a).
Plk3 is involved in regulation of the Gl/S phase transition and is required for
entry into S phase (Wedy C et al, 2007). Recent studies have shown that Plk3
phosphorylates Cdc25C on serine 191, and to a lesser extent serine 198, within the
nuclear export signal (NES) to promote the nuclear accumulation of Cdc25C, and that
substitution of serine 191 with an alanine abrogates Cdc25C's nuclear localization
(Bahassi et al, 2004). Transient transfection of cells with wild-type Plk3 but not with
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a kinase dead Plk3 results in a marked increase of Cdc25C in the nucleus. This
nuclear accumulation of Cdc25C is inhibited when Plk3 is suppressed by siRNA,
implicating the involvement of Plk3 in the nuclear accumulation of Cdc25C (Bahassi
et al, 2004).
Therefore, the Polo-like kinases act as important coordinators for intracellular
localization of active MPF by directing nuclear entry of MPF and its activator
Cdc25C, which may be essential for coordinating M-phase events.
ii)

Mitotic Exit
In all eukaryotic organisms, exit from mitosis requires the inactivation of

mitotic Cdkl activity, and this step is a prerequisite for the onset of cytokinesis.
Unlike other eukaryotic organisms, downregulation of Cdkl activity in mammalian
cells occurs at the metaphase/anaphase transition (Clute and Pines, 1999), while the
inactivation of budding yeast Cdkl occurs after metaphase/anaphase transition
(Ghiara et al, 1991; Surana et al, 1993), and it is achieved through the successive
actions of two cooperative pathways termed FEAR (Cdc Fourteen Early Anaphase
Release) network (Stegmeier et al, 2002) and MEN (Mitotic Exit Network) (Bardin
and Amon, 2001; Jensen and Johnston, 2002). The FEAR and the MEN must be
activated in an ordered manner, but how this order is maintained is not known. Both
genetic and biochemical analyses showed that Cdc5 plays an important role in
regulating both of these pathways and Cdc5 may coordinate these two pathways,
perhaps by directly phosphorylating and regulating components in each pathway.
Studies show that the Xenopus Polo-like kinase Plxl is required in mitotic
exit. The metaphase to anaphase transition could be blocked by immunodepletion of
Plxl, and was restored upon the addition of recombinant Plxl (Qian et al, 1999; Liu
et al, 2004). These results demonstrate that the metaphase/anaphase transition
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requires active Plxl. Furthermore, Plxl associates with the anaphase-promoting
complex/cyclosome (APC/C). Studies so far have demonstrated three possible
mechanisms that Plxl regulate APC/C activity. First, Plxl may activate APC/C by
direct phosphorylation of several APC/C subunits (Kotani et al, 1998). The second
mechanism may involve the regulation of APC/C activators or inhibitors by Plxl.
Thirdly, Plxl is also required to prevent premature inactivation of the APC/C
(Brassac et al, 2000).
iii)

Cytokinesis
Polo-like kinases have been shown to play a role in cytokinesis, and much of

the evidence came from studies on the fission yeast (Schizosacchromyces pombe
(Ohkura et al, 1995; Bahler et al, 1998), Drosophila (Carmena et al, 1998), and
more recently, the budding yeast {Sacchromyces cerevisiae) (Song and Lee, 2001). In
budding yeast, besides the role in mitotic exit, Cdc5 is required for proper actin ring
formation at the mother-bud-neck (Jimenez et al, 1998; Frenz et al, 2000; Lee et al,
2001). Consistent with the role in cytokinesis, Cdc5 localizes to the neck as early as
G2 and remains at this structure until late mitosis (Sakchaisri et al, 2004), suggesting
of additional role(s) at the neck. Furthermore, depletion of Cdc5 results in arrests at
multiple points during mitosis, suggesting a failure of cytokinesis (Song and Lee,
2001).
In fission yeast, loss of Plol function leads to the generation of multinucleate
cells with defects in actin ring and septum formation, suggesting that Plol activity
may be required for cytokinetic events. In early mitosis, Plol localizes to the future
division site (Bahler et al, 1998; Mulvihill et al, 1999), and this localization appears
to be important for the placement and organization of an actin-based medial ring
(Bahler et al, 1998). Secondly, Plol activation correlates with the timing of septum
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formation, which is regulated by a signaling network termed septation initiation
network (SIN) (Bardin and Anion, 2001; McCollum D, 2001; Gruneberg and Nigg,
2003). The SIN in fission yeast is composed of proteins structurally related to those in
the MEN and they function at each tier of the pathway. In addition, in the absence of
Plol activity, formation of a division septum is impaired in fission yeast, whereas
overexpression of Plol leads to formation of an ectopic septum.
In

Drosophila,

it

was

shown

that

Polo

kinase

and

Pav-KLP

coimmunoprecipitate, and they co-localize in the central part of the spindle. The PavKLP family of motor proteins play a conserved role in organizing the central spindle
in anticipation of cytokinesis. Furthermore, cytokinesis can fail at all stages of
spermatogenesis in polo mutants (Carmena et al, 1998). Also, the Drosophila Polo
was found to interact with CHOI homolog Pavarotti, which is implicated in
cytokinesis (Adams RR et al, 1998). In Xenopus, Plxl has been shown to play a role
in cytokinesis. Similarly, Plxl is localized to the midbody in late mitosis in Xenopus
embryos (Qian et al, 1999). Interestingly, the inactivation of Plxl may also be
required for completion of cytokinesis in Xenopus embryos (Qian et al., 1999). It
seems that the initiation of cytokinesis requires the activity of Plks, and the
completion of cytokinesis requires their inactivation or degradation.
Mammalian Plkl has also been implicated in cytokinesis, consistent with Plk
localization to the midzone late in mitosis. The first evidence of the involvement of
Plkl in cytokinesis was the identification of the kinesin-like protein CHOl/MKLP-1
as an in vitro substrate of Plkl, which induces microtubule bundling and antiparallel
movement in vitro (Lee KS et al., 1995). On the other hand, overexpression of Plkl
does give rise to multinucleated cells (Mundt KE et al, 1997), indicating the precise
level of Plkl may be important for the correct execution of cytokinesis. Evidence for
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a role for Plkl in cytokinesis was also found in overexpression studies with a
dominant negative mutant of Plkl, which causes a failure in completion of cytokinesis
after forced inactivation of the spindle assembly checkpoint (Seong YS et al, 2002).
In addition, Plkl has been found to phosphorylate several other proteins that are
involved in cytokinesis, like NudC, a component of the dynactin complex (Zhou T et
al, 2003). MKlp2, a kinesin localized to the midbody in cytokinesis (Neef R et al,
2003). Finally, the Rho exchange factor ECT2 is another Plkl substrate recently
implicated in cytokinesis (Niiya F et al, 2005).
These observations strongly suggest that Plks play a role in both the
organization of the central spindle and the correct execution of cytokinesis.

The Polo Box Domain
In Plks 1-3, studies have shown that the PBD made up of polo box 1 (PB1)
and polo box 2 (PB2) motifs, a linker of 20 residues and 45 residues upstream of PB1
is a functional domain of approximately 80 amino acids (Cheng et al, 2003), It
consists of a continuous six-stranded antiparallel p-sheet and an a-helix. The PBD
regulates the cellular function of the Plks, subcellular localization and substrate
interactions (Seong YS et al, 2002; Elia AE et al, 2003; Reynolds N., 2003). It is
thought to localize the respective kinase to various mitotic structures during cell cycle
progression, including centrosomes in early M phase, the spindle midzone in early
and late anaphase and the midbody in cytokinesis, presumably to promote interaction
between its catalytic domain and specific substrates and effectors (Lee et al, 1998;
Jang et al, 2002a). For example, Polo-like kinases have been shown to interact with
Cdc25C (Kumagai and Dunphy, 1996; Ouyang et al, 1999), and this interaction is
polo box-dependent (Elia et al, 2003b). Mutation of the putative Plkl pThr-binding
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motif in Cdc25C indeed abolishes interaction between Cdc25C and the Plkl-PBD,
and decreases phosphorylation of Cdc25C (Elia et al, 2003).Furthermore, residues
Trp-414, Val-415 and Leu-427 in PBD all contribute to proper Plk localization and
function in various Plk family members, including budding yeast Cdc5, fission yeast
Plol, murine Plk and human Plkl.Trp 414 in PB1 of human Plkl has been suggested
to play a critical role in PBD substrate binding (Elia et al, 2003b). Mutation of this
residue to phenylalanine dramatically affects the ability of human Plkl to complement
the Cdc5-1 defect in yeast and disrupts Plk localization at spindle poles and septin
ring structures (Lee et al, 1998). Mutation of the residue analogous to Trp-414 in
Xenopus Plxl and Val-415 in budding yeast Cdc5 inhibits interaction with substrates,
such as the APC/C subunit Cdc27 (Liu J et al, 2004). In addition, Plxl function in
bipolar spindle formation (Qian et al, 1998a) has also been demonstrated to be polo
box dependent (Liu et al, 2004). Studies identified that the optimal sequence motif
recognized by the PBD is Ser-[pSer/pThr]-[Pro/X], suggesting that Cdks, MAP
kinases, and other mitotic kinases might generate 'priming' phosohorylations on
substrates or docking proteins to localize Plks in the vicinity of their substrates (Elia
et al, 2003). At present, verified in vivo Plkl substrates include Cdc25C (Toyoshina
Morimoto et al, 2002), Brca2 (Lin et al, 2003), Myl(Nakahjima et al, 2003), Cyclin
B (Toyoshima-Morimoto et al, 2001), NudC (Zhou et al, 2003), Nip (Casenghi et
al, 2003), TCTP (Yarm, 2002), Mklpl (Lee et al, 1995; Liu et al, 2004), Chk2
(Tsvetkov et al, 2003), MKIp2 (Neef et al, 2003), and Weel (Sakchaisri et al, 2004;
Watatnabe et al, 2004). All of these contain potential PBD-binding sites. Other
substrates of the Plk family members have been identified are summarized and listed
in Table 1.
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Table 1. Summary of identified proteins interacting with the polo-like kinases
Cdc5

Plol

Polo

Plxl

Plkl

Hsll

Midi

Asp

Cyclin B

Cyclin Bl

Swel

Byr4

Cdc25

Cdc25C

Cdc25C

Chk2

Cdcll

Weel

pol

Handl

Cdcl2

Mytl

p53

Chk2

Sccl

NudC

Bfal

TCTP

Bbpl

CHOl/MKLPl

Nudl

a-tubulin

Spc72

P-tubulin
y-tubulin
Chk2
Nip
Emil
Pinl
BRCA2
GRASP65

Plk2
SPAR

Plk3
Cdc25C

Sak
Cdc25C
p53

Plks and Centrosomes
Centrosomes are the microtubule-organizing centers (MTOC) and are
important for the formation of the bipolar spindle during mitosis. They contain a pair
of microtubule-based

centrioles and surrounding pericentriolar material. The

centrioles duplicate once during the cell cycle to give rise to two mitotic spindle
poles. So, cells normally contain one or two centrosomes depending on their phases in
the cell cycle. Centrosome duplication starts at later Gl phase and proceeds through S
phase (Fukida S et al, 2002). Prior to mitosis, the duplicated centrosomes separate
and move to the future poles of the spindle to initiate the bipolar spindle, this is
required for equal segregation of chromosomes. Duplication of a single centrosome
must be precisely coordinated with the duplication of the genome to ensure faithful
transmission of genetic material. Aberrant centrosome numbers can result in the
generation of monopolar and multipolar spindles. Centrosome abnormalities are
implicated in chromosomal instability and in the development of cancer, and many
cancer cells display multiple centrosomes or enhanced centrosomal activity (Li et al,
2001). Extent research has indicated that polo-like kinases family plays a pivotal role
in the regulation of the centrosome duplication and maturation (Glover et al, 1996;
Wiannyefa/., 1998).
In budding yeast, Cdc5, a homologue of the Plks is required for spindle pole,
the functional counterparts to centrosomes, and for the formation of normal mitotic
spindles. The evidence indicating a role for Cdc5 in regulating the spindle pole body
(SPB) came from the study of meiosis I in budding yeast (Schild and Byers, 1980). A
temperature-sensitive mutant of Cdc5 fails to complete meiosis I due to arrest at a
stage after SPB duplication and separation at the restrictive temperature. In these
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mutant cells, SPBs lack the normal spindle microtubules that are characteristic of
meiosis I in wild-type cells.
In fission yeast, Plol is required for the assembly and function of the mitotic
spindle. Both loss of Plol function and over-expression of this gene results in
formation of cells in which condensed chromosomes are associated with monopolar
spindles (Ohkura et al, 1995), indicating a failure in bipolar spindle formation.
In Drosophila, embryos from homozygous polo females display abnormal
spindles which are multiple branched spindles in syncytial polo-derived embryos,
spindles with broad poles and fewer circular mitotic figures in larval neuroblasts
(Sunkel and Glover, 1988). While in strongly hypomorphic mutants (polo9/10), a
majority of cells are arrested in a metaphase-like stage lacking asters at each spindle
pole and they all possess bipolar spindles with robust arrays of microtubles
(Donaldson et al, 2001).
In embryonic Xenopus cells, Plxl is localized to mitotic spindles. In early
prophase, Plxl has a bipolar localization at the spindle poles and colocalizes with ytubulin. Inhibition of Plxl by microinjection of anti-Plxl antibodies into Xenopus
embryos resulted in monopolar spindles with altered patterns of a-tubulin associated
with a radial distribution of chromosomes around the pole (Qian et al, 1998a). The
exact mechanism by which Plxl regulates bipolar spindle formation is not clear.
However, evidence from studies in mammalian cells suggests that Plxl most likely
affects bipolar spindle formation by regulating both centrosome separation and
maturation. It is therefore likely that Plxl regulates centrosome separation and
maturation by recruiting specific proteins necessary for these processes to
centrosomes.
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Several mammalian Plks are involved in regulating centrosomal function
although the molecular basis of their roles remains unclear. Plkl was first implicated
in the centrosome cycle because of its centrosomal localization during interphase and
its association with mitotic spindle poles in early mitosis (Golsteyn et al, 1994). Plkl
antibody injection studies show that Plkl is also essential for centrosome separation,
with defects leading to monopolar spindles and consequent mitotic arrest (Lane HA et
al, 1996). Plkl depletion by siRNA significantly reduced centrosome amplification
(Liu and Erikson, 2002). Plkl interacts and phosphorylates a-, p- and y-tubulins and
the tubulin-atabilizing protein TCTP (Feng Y et al, 1999; Yarm FR et al, 2002),
indicating that Plkl may regulate spindle formation through centrosome maturation
and separation as well as by directly regulating tubulin functions.
Plk2 also plays an important role in the reproduction of centrosomes. The
study showed that the polo-box of Plk2 is required for the centrosome and centriole
duplication. Mutation of Plk2 polo-box impairs centrosomal localization and centriole
duplication. Plk2 is localized to centrosomes during early Gl phase and only
associates to the mother centriole. Furthermore, the results suggest that Plk2 mediated
centriole duplication is dependent on Sak function. In addition, the downregulation of
Plk2 leads to abnormal mitotic spindles, indicating that Plk2 may have a function in
the reproduction of centrioles (Cizmecioglu O et al, 2008).
Plk3 primarily localizes to the microtubule organization center during
interphase. In all stages of the cell cycle Plk3 is associated with centrosomes or
mitotic spindle poles (Wang et al, 2002). It remains unclear why both Plkl and Plk3
are localized to centrosomal regions during interphase. Thus, Plks may fulfill different
functions in regulating microtubule dynamics during the cell cycle.
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Plks and DNA Damage Checkpoint Pathways
The progression of the cell cycle is tightly regulated in order to maintain
genetic integrity and to ensure that genetic information is correctly passed on to
daughter cells. Surveillance mechanisms, known as checkpoints monitor the integrity
of cell cycle progression (Elledge, 1996). The checkpoints are activated in response to
DNA damage caused by environmental stress and /or internal perturbations. Various
types of DNA damage activate DNA damage checkpoint pathways that arrest cells at
the Gl/S border (Gl-phase checkpoint), delay S-phase progression (intra-S-phase
checkpoint), or prevent mitotic entry (G2-phase checkpoint), depending on the phase
of the cell cycle in which the damage occurs. DNA damage induces several cellular
responses including DNA repair, checkpoint activity and the triggering of apoptotic
pathways depending on the severity of the damage and the cell context.
Cell cycle regulatory proteins are targets and effectors of DNA damage
checkpoint pathways. Two protein kinases, ATM (ataxia telangiectasia mutated) and
ATR (ataxia telangiectasia and Rad-3-related) are at the top of signaling cascades that
transmit the signals downstream to mediators (Chkl and Chk2) and effectors (p53,
p21, Cdc25A, Cdc25C). Polo and Polo-like kinases have emerged as major regulators
for various cell cycle checkpoints. Extensive research has demonstrated that the Plks
are important mediators for various cell cycle checkpoints that monitor centrosome
duplication, DNA replication, formation of bipolar mitotic spindle, segregation of
chromosomes, and mitotic exit, thus protecting cells against genetic instability during
cell division (Nigg, 1998; Dai et al, 2002; Barr et a!., 2004). In response to DNA
damage, budding yeast arrests in metaphase with active Clb-Cdc28, but eventually
continues through the cell cycle even if the damage is not repaired. However, a
mutation in CDC5 (cdc5-ad) completely eliminates the ability of these cells to over-
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ride cell cycle arrest even in the presence of an irreparable double-strand DNA break
(Toczyski et al, 1997), suggesting a role for Cdc5 in overriding the DNA damage
checkpoint (Sanchez et al,

1999). It remains to be determined how Cdc5

downregulates the DNA damage checkpoint pathway and what it targets for
adaptation.
Several studies show that the activity of Plkl is inhibited after DNA damage
(Smits et al, 2000; van Vugt et al, 2001; Ando et al, 2004). However, expression of
activation mutants of Plkl can override the G2/M arrest induced by DNA damage
(Smits et al, 2000). In addition, Plkl can bind to p53 which plays an important role in
maintaining genomic fidelity by controlling cell cycle checkpoints and apoptotic
process in response to genotoxic stress (Levine, 1997). Plkl

inhibits p53

transactivation activity and its pro-apoptotic function, whereas the kinase-deficient
mutant form of Plkl failed to reduce the transcriptional activity of p53. Besides, Plkl
and Chk2 have been shown to colocalize at centrosomes in early mitosis and to the
mid-body in late mitosis (Tsvetkov et al, 2003). Plkl also interacts with and
phosphorylates Chk2 (Tsvetkov L et al, 2003). Overexpression of Plkl enhances
phosphorylation of Chk2 at T68 (Tsvetkov et al, 2003), a site primarily targeted by
ATM in response to ionizing radiation, leading to its activation (Matsuoka et al,
2000). Another substrate of Plkl involved in the DNA damage checkpoint is the
breast cancer susceptibility protein, BRCA2, which is essential for the repair of DNA
double-strand breaks (Lin HR et al, 2003; Lee M et al, 2004). Plkl phosphorylates
BRCA2 during mitosis (Lin et al, 2003; Lee et al, 2004). The phosphorylation of
BRCA2 is inhibited by DNA damage, which is consistent with the finding that Plkl
activity is negatively regulated by DNA damage (Smits et al, 2000). Therefore, after
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DNA damage, the activity of Plkl is inhibited, leading to activation of p53 and
modulation of Chk2 and BRCA2.
Other mammalian Plks are also involved in the DNA damage checkpoint
activation pathway. Expression of Plk2 mRNA is rapidly induced upon X-ray
irradiation; Plk3 kinase activity is activated upon oxidative stress and DNA damage
induced by ionizing-radiation mimetic drugs, and its activation is ATM-dependent
(Xie et al, 2001a, b). Plk3 interacts with and phosphorylates p53; targeting serine-20
of p53 in vitro (Xie et al, 2001b) and the extent of this interaction is increased in
response to DNA damage (Xie et al, 2001b). Plk3 also physically interacts and
phosphorylates with Chk2 during DNA damage checkpoint activation (Bahassi et al,
2002). Together, these studies suggest that Plk3 functionally links DNA damage to
the induction of cell cycle arrest or apoptosis. Furthermore, Plkl is inhibited in
response to DNA damage, Plk3 is activated suggesting that both kinases have
opposing roles in checkpoint control (Xie et al, 2001).
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Figure 2. Major pathways where Plks may play a role in checkpoint in
mammalian systems. Arrows and bars denote the positive and negative regulations,
respectively. Dotted lines denote where the regulatory role in vivo between these
proteins remains to be elucidated.

PIks and Oncogenesis
Polo-like kinases play an important role in the centrosome cycle. Mutations of
Plks from Polo, CDC5, Plol to Plkl, Plk2, Plk3 resulted in aberrant centrosome
numbers. Centrosome abnormalities are implicated in chromosomal instability and in
the development of cancer. Extensive studies have shown that deregulated expression
of Plks is detected in many types of cancer and is associated with oncogenesis.
Plkl expression is elevated in non-small-cell lung cancer (Wolf et al, 1997),
head and neck cancer (Knecht et al, 1999), esophageal cancer (Tokumitsu et al,
1999), melanomas (Strebhardt et al, 2000), breast cancer (Wolfe? al, 2000), ovarian
cancer (Takai et al., 2001a), endometrial cancer (Takai et al, 2001b), colorectal
cancer (Macmillan et al, 2001), gliomas (Dietzmann et al, 2001), and thyroid cancer
(Ito et al, 2004). Results from these studies indicate that overexpression of Plkl is
positively correlated with aggressiveness and prognosis in many cancers. Moreover,
inhibition of Plkl with various techniques results in growth arrest or apoptosis for the
cancer cells. Thus, Plkl could be a novel prognostic marker and a good target for
chemotherapeutic intervention. The link between Plkl and oncogenesis may be due
to several interacting partners of Plkl that are encoded by tumor suppressor genes. It
has been reported that Plkl is able to phosphorylate the p53 protein in vitro (Xie et
al, 2001). Over 50% of human cancers contain mutations in the gene coding for p53.
Plkl also phosphorylates the breast cancer susceptibility protein BRCA2 during
mitosis, BRCA2 (Breast Cancer Type 2 susceptibility protein) is a human gene that is
involved in the repair of chromosomal damage and belongs to tumor suppressor
genes. The phosphorylation of BRCA2 is inhibited by DNA damage which can cause
an increased risk for breast cancer. Chk2 (checkpoint kinase2) that is implicated in
DNA repair processes, is also considered as a tumor suppressor protein. It has been
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showed that Plkl can phosphorylate Chk2 at Thr-68, a site that is phosphorylated by
ATM. ATM and ATM- and Rad3 related (ATR) are two tumor suppressor proteins
with phosphotransferase activity. ATM plays a very important role in the linkage of
DNA damage and the induction of a subsequent cell cycle arrest (Zhou and Elledge,
2000). DNA damage activated ATM positively regulates the activation of other
checkpoint kinases, like Chkl and Chk2 (Matsuoka et al, 2000), and phosphorylates
p53, MDM-2 and BRCA1 (Khosravi et al,

1999). At the G2-DNA damage

checkpoint inhibition of Plkl activity depends on ATM/ATR activity (van Vugt et al,
2001). Taken together, Plkl interacts with several tumor suppressor proteins. On the
one hand, Plkl phosphorylates p53, Chk2 and BRCA2 possibly to promote mitotic
progression. On the other hand, Plkl is inhibited by tumor suppressor proteins like
ATM, ATR, BRCA1 and Chkl.
Plk2 may primarily function as a regulator of Gl progression in mammalian
cells (Ma et al, 2003a). Plk2 is transcriptionally regulated by p53 (Burns et al, 2003)
and expression of Plk2 is induced in a p53-dependent manner after DNA damage
(Burns et al, 2003). Silencing of Plk2 by siRNA was followed by an increase in
apoptosis.
Several studies have examined Plk3 expression in human tumor specimens.
Plk3 expression levels are downregulated in lung tumor specimens compared with the
normal tissue (Li et al, 1996). Also, Plk3 mRNA downregulation has been detected
in uterus (Ando et al, 2004), bladder (Ando et al, 2004), and head and neck
squamous cell carcinoma (Dai et al, 2000) specimens. In summary, Plk3 gene
expression appears to decrease during the development of some, but not all, types of
tumors. Since Plk3 may primarily function in the DNA damage response pathway,
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reduced Plk3 levels could contribute to the genomic instability characteristic of tumor
cells.
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CHAPTER II
SAK/PLK4 BACKGROUND

Sak Structure
Sak (also called Plk4) was the last member of the polo-like kinase family to be
identified in vertebrates. Similar to the other Plks, Sak has a kinase domain at its Nterminus; however Sak appears to have diverged significantly from a primordial Plk
early in the radiation of metazoans (Fode et al., 1994). The kinase domain of murine
Sak is followed by 660 amino acids containing a single 64 amino-acid PBD at the
COOH end. The Sak-pb is equally related by phylogenetic comparison to the pbl and
pb2 domains of other Plks. The polo box domain functions as a docking site for
various phosphorylated proteins. The C-terminus of Sak contains 3 PEST sequences,
which are commonly associated with reduced protein stability. And Sak protein
displayed a short half life (2-3 h) in nonsynchronized cells (Fode et al., 1996). The
removal of PEST sequences from Sak enhances the stability of the protein (Yamashita
et al., 2001). The upstream region of the Sak-pb domain is designated the 'cryptic
polo box' (cry-pb) (Sak596-836) which binds to the Tec tyrosine kinase and stabilizes
the protein by protecting it from PEST-dependent proteolysis (Yamashita et al.,
2001). Like the other Plks, Sak has been shown to be a functional kinase with known
substrates including p53 (Ko et al, 2005; Swallow et al 2005), Handl (Martindll et al.
2008), Cdc25C (Bonni et al. 2008) and Chk2 (Petrinac et al. in press 2009). Sak
kinase activity is markedly increased by a SakT170D mutation in the T loop, while
SakK41M, an inactivating mutation in the ATP-binding domain, eliminates activity.
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Figure 3. Structural features of Sak. Sak has a Ser/Thr kinase domain at the
amino-terminus, a single PB motif at the carboxy-terminus, and three PEST
destruction motifs. The conserved ATP-binding domain with the required Lys41
residue and the T-loop activation domain with the required Thrl70 are indicated. The
cry-pb interacts with the Sak kinase domain.

Sak Expression and Localization
Sak mRNA expression is relatively low in both quiescent, GO phase cells and
in early-to-mid-Gl phase cells and then increases beginning in the late Gl phase, then
increases in S through G2 phase, and peaks in M phase. This expression pattern is
consistent with the mitotic functions of Sak (Winkles JA et al., 2005). Whether Sak
protein levels and kinase activity are regulated in a similar manner is presently
unknown. However, it was reported that Sak expression is associated with mitotic and
meiotic cell division in mouse tissues (Fode C et al, 1994). Sak gene expression in
mammalian cells is also controlled at the post-transcriptional, protein degradation
level. Sak protein is ubiquitinated and destroyed at M phase by the APC/C (Fode C et
al., 1994), similar in this regard to Cdc5 (Shirayama et al, 1998).
Sak mRNA expression has been detected in only a few adult tissues by
Northern blot hybridization analysis. In the mouse, Sak mRNA was found at the
highest level in the testis, a tissue containing actively dividing somatic and germ cells,
at an intermediate level in the spleen and thymus, and not at all in the brain, heart,
kidney, liver, or ovary (Fode et al, 1994).
The subcellular localization of epitope-tagged Sak is different from that of
endogenous Sak. It is reported that GFP-Sak localized to the nucleolus in G2 and to
centrosomes in early M phase (Hudson et al. 2001). During anaphase, GFP-Sak
appeared to be dispersed throughout the cell, and at telophase the fusion protein was
localized to the midbody cleavage furrow. Perinuclear localization of GFP-Sak was
observed in interphase cells (Hudson JW et al, 2001). This is in contrast to
observations of endogenous Sak which was found to associate with centrosomes
throughout the cell cycle, as indicated by its co-localization with centrin, C-Napl and
y-tubulin (Habedanck R et al, 2005). Interestingly, a recent study showed that both
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endogenous Sak and ectopic GFP-Sak localizes nucleolar in Rcho-1 cells
synchronized in G2/M following nocodozole treatment and endogenous Sak localizes
to a single nucleolus, whereas a GFP-Sak fusion protein is ectopically localized to
multiple nucleoli (Martindill DMJ et al, 2007).

Sak Null Mice
To study the role of Sak in embryonic development, a Sak null allele was
generated. The murine Sak null phenotype was found to be embryonic lethal with
embryos arresting at E7.5. Sak null embryos display a marked increase in mitotic and
apoptotic cells. In addition, many of these cells are in late anaphase or telophase with
abnormally high levels of Cyclin Bl and phosphorylated histone H3. This suggests
that Sak is essential for exit from mitosis and cell viability (Hudson et al, 2001).

Sak and Centrosomes
The observation that endogenous Sak localizes to centrosomes led to further
functional studies on Sak function which indicate a key role for Sak in centriole
duplication. Interestingly, overexpression of wildtype Sak in U2-OS and HeLa cells
resulted in a multiplication of Sak-positive signals which co-localize with centriole
markers (Habedanck R et al, 2005). Downregulation of Sak in Drosophila cells by
mutation leads to loss of centrioles (Bettencourt-Dias M et al, 2005). Furthermore,
depletion of Sak, but not Polo, leads to the generation of cells with a reduced number
of centrioles. Centriole loss in a cycling population of cells can arise through
defective centrosome duplication, abnormal separation of centrosomes at entry to
mitosis, or abnormal centrosome segregation to the daughter cells in cytokinesis
(Bettencourt-Dias M et al, 2005). In addition, antibody-microinjection demonstrates
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that suppression of Sak function interferes with centrosome overduplication. When
HeLa cells were transfected with siRNA duplexes that targeted Sak, after depletion of
Sak for 24 h, the vast majority of cells still exhibited bipolar spindles. However, after
48 h, many monopolar spindles were observed. The results demonstrate that cells
depleted of Sak undergo a step-wise loss of centrioles through the cell cycle,
indicating that Sak is indispensible for centriole duplication (Habedanck R et al,
2005).
Cyclin-dependent kinase 2 (Cdk2) is localized to centrosomes and has
previously been implicated in the regulation of centriole duplication in different
species (Lacey KR et al, 1999). Overexpression of Sak cannot cause centrosome
amplification in the absence of Cdk2 activity. Conversely, Cdk2 is not able to cause
centrosome overduplication in the absence of Sak, indicating that Sak acts in
cooperation with Cdk2. This shows that Sak is not the sole regulator of centriole
duplication and further work need to unravel the integration of the Sak pathway with
cell-cycle control of centrosome duplication.
Both gain- and loss-of-function experiments demonstrate that Sak is required
for the precise reproduction of centrosomes during the cell cycle. These observations
strongly support a model in which Sak is a crucial regulator of centriole duplication in
human and Drosophila cells.

Sak and Cell Cycle Damage Pathways
The activation of the Cdc25 and the p53 affects at least three stages at cell
cycle: the Gl/S transition, S phase progression and the G2/M boundary (Samuel T et
al, 2002; Latonen L et al, 2005). Sak was identified as a p53 target gene and was
shown to be repressed by p53. Furthermore, Sak interacts and phosphorylates Cdc25C
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which is one of the three members of the Cdc25 family of phosphatases in
mammalian cells. The Cdc25 phosphatases function as key regulators of the cell cycle
during normal eukaryotic cell division and as mediators of the checkpoint response in
cells after DNA damage (Busch C et al., 2007). Cdc25C is active at the late G2-phase
of the cell cycle. Sak has also been showed to interact with ATM, ATR, Chkl and
Chk2 (Petrinac MSc thesis; Petrinac et al, in press 2009) and to phosphorylate Chk2
(Petrinac et al, in press 2009) Therefore, these findings suggest that Sak may be an
intermediate in the pathways regulating DNA damage responses and checkpoint
arrest.

Sak and Mitosis
Sak may primarily play a role in M phase progression (Hudson et al, 2001)
and this possibility is supported by data demonstrating Sak mRNA expression is
relatively high in the G2, and M phases. A proposed role for Sak in mitosis is
supported by the observation that Sak phosphorylates Cdc25C (Bonni et al, 2008).
Cdc25C which regulates the activity of the mitosis promoting factor Cyclin B/Cdkl
by dephosphorylation, thus triggering G2/M transition. Additionally, both the Sak null
mouse model and cells derived form the Sak mouse support a role for Sak in mitosis
and mitotic exit (Hudson JW et al, 2001). Null embryos display cells in late anaphase
or telophase that continue to express Cyclin Bl and phosphorylated histone H3.
Normally during normal mitotic progression Cyclin Bl and phosphorylated histone
H3 are lost during the metaphase to anaphase transition. This implicates Sak with a
role in chromosomal segregation and exit from mitosis (Hudson JW et al, 2001).

Sak and Cancer
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The Sak gene is found on Mouse-Chromosome 3 and Human- Chromosome
4q28. A region frequently undergoes rearrangement or loss in human cancers
(Hammond et al, 1999). Sak heterozygous mice are fertile. However, at age of 18-24
months, Sak + " mice developed apparent tumors at the liver and the lung, suggesting
that reducing levels of Sak are associated with tumor formation. The lesions of
heterozgyous mice liver were primary liver carcinoma, which were typically
multifocal (Ko et al. 2005). Additionally, studies suggest that Sak kinase regulates
both Cdkl and APC/C and, thereby, entry into and exit from mitosis (Ko MA et al.,
2005). Cyclin Bl, phosphorylated Cdkl and securin levels were reduced in Sak+A
livers after partial hepatectomy, consistent with a delay in reaching anaphase (Ko MA
et al., 2005). Sak RNA and protein expression were retained in both spontaneous and
partial hepatectomy-induced tumors, suggesting that the increased incidence of
hepatomas in Sak+/~ mice resulted from haploinsufficiency and that Sak gene dosage is
important to suppression of carcinogenesis. Murine embryonic fibroblasts (MEFs)
derived from Sak + " mice have an about 2 fold greater doubling time compared to
Sak+/+ MEFs which suggests that the heterozygous Sak MEFs are haplo-insufficient
for cell cycle progression.
Furthermore, Sak overexpression may also play a role in tumourigenesis. It
has been reported that Sak is overexpressed in colorectal tumors (Eckerdt F et al.,
2005). Overexpression of Sak leads to multimucleation (Habedanck R et al, 2005).
Increased centrosome number leads to genomic instability which in turn can
contribute to oncogenic transformation.
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Objectives of this Study
While there is a considerable amount of information regarding the phenotypes
associated with Sak overexpression and depletion in centrosome duplication,
development and tumourigenesis, little is known regarding Sak interacting partners
and potential substrates. Kinases in general tend to be promiscuous, targeting and
interacting with numerous other proteins, however, less than a handful of Sak targets
have been established. The Plks, in general, often interact with and target the same
proteins or components of the the same cellular pathways; thus placing these
proteins/pathways under tighter or opposing control. Therefore, the objective of the
current investigation was to identify interacting partners and substrates for Sak. In
order to accomplish this, an approach was employed in which known interacting
partners for other Plks or proteins known to localize and effect similar cellular
functions as Sak were tested as candidates for interaction.
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CHAPTER III
MATERIALS AND METHODS

Preparation Escherichia coli (E. coli) Competent Cells
Top 10 F Pilus E. coli cells from the frozen glycerol stock were streaked out
onto LB agar plates, the plates were incubated at 37°C for overnight, then a single
colony was picked and inoculated a starter culture of lOmL TYM medium which was
incubated for approximately 16 hours at 37°C with vigorous shaking (approx.
250rpm). lmL of starter culture was added to lOOmL prewarmed TYM media and
cells were grown in 37°C shaker, OD600 was measured every 45 minutes-lhour until
OD600 equaled 0.5(log phase growth), then the cultures were placed on ice with
gently swirling for 5 minutes until cold. The culture was transferred to a sterile
250mL centrifuge tube and centrifuged at 4000 rpm for 10 minutes at 4°C, then
decant the supernatant and the pellet was resuspended in 30mL cold TfBI buffer
gently using chilled pipettes. The cells were again centrifuged at 4°C for 10 minutes at
4000 rpm and the supernatant was carefully discarded. The pelleted cells were
resuspended in 4mL ice-cold TFBII buffer and lOOuL aliquots were quickly placed
into sterile microcentrifuge tubes. The aliquots were frozen in liquid nitrogen and
stored at -80°C.

Transformation and DNA Purification
Plasmid DNA was amplified in competent cells in order to obtain sufficient
plasmid DNA needed for subsequent experimental procedures. Competent E. coli
cells (Top 10 F Pilus) were thawed and kept on ice to ensure high transformation
efficiency, 0.5-lug of DNA was added to lOOuL of competent cells and mixed gently
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by pipetting up and down, then the cells were incubated on ice for at least 30 minutes,
after this, the cells were heat shocked at 42°C for 40 seconds and then immediately
place tubes on ice for 2 minutes. 500uL of LB medium was then added and the cells
were incubated for 45 minutes at 37°C. IOOUL of the transformation mix was spread
onto antibiotic LB-agar plates. The cells were grown by putting the plates up side
down at 37°C incubator. The next day, a single colony was picked and inoculated in
250mL of LB medium containing the appropriate selective antibiotic incubate for 16
hours at 37°C. The DNA was purified using Qiagen Plasmid Maxi Prep Kit (Qiagen
Inc.) according to the manufacturer'protocol. DNA concentration was determined by
UV spectrophotometry at 260nm.

Boiling Mini Preps
The transformation experiment was first performed using the desired DNA.
After about 16 hours at 37°C, the colonies were observed. Then were picked and
grown in 2mL of LB media containing the appropriate selective antibiotic for
overnight. 2mL growth culture was transferred into an Eppendorf tube and
centrifuged at 4000x for 5 minutes. The supernatant was then removed using
aspirator. The cell pellets were resuspended in 100 uL of boiling mini prep solution
(8% glucose, 5% Triton X-100, 50mM EDTA, 50mM TRIS pH 8.0, lOmg/mL
lysozyme), and boiled for 30 seconds in a hot water bath. The lysed cells were placed
on ice for 30 minutes, and centrifuged at 40°C for 15 minutes at 4000x g. The
supernatant, which contained the desired plasmid DNA, was then transferred to a
fresh Eppendorf tube. Finally, 5uL DNA was used in a 20 ul reaction for diagnostic
restriction digests.
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Cell Culture
HEK-293, NIH 3T3, U2-0S, SaOS-2 cells were cultured in Dulbecco's
modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine Serum
(FBS) (Sigma), 1% penicillin-streptomycin (Gibco). All cell lines were maintained at
37°C in a humidified atmosphere containing 5% C02. Sf9 cells (a kind gift from Dr.
Lisa A. Porter, University of Windsor) were cultured in Grace's insect medium
(Sigma) supplemented with 10% Insect Medium Supplement 10X (Sigma) and 1%
penicillin- streptomycin (lOOug/mL) (Gibco). Sf9 cells were grown at 27°C.

Transfection and Cell Lysis
1.0 xl0 6 HEK 293 cells were seeded onto 10cm tissue culture dishes. 24 hours
later, 6ug of DNA per plate was transfected using Effectene TM (Qiagen) according
to the manufacturer's recommendations. Approximately 16 hours post- transfection,
cells were harvested by centrifugation at 250 x g for 5 minutes. The medium was
removed and the cells were washed three times with lxPBS, then the cells were lysed
with lmL ice cold lysis buffer containing Protease Inhibitor Cocktail. The lysed cells
were allowed to sit on ice for 20 minutes, then scraped off the plates and collected in
eppendorf tubes. The lysates were clarified by centrifuging at 3,000 x g for 20
minutes at 4°C.

Immunoprecipitation
Immunoprecipitation of FLAG-tagged expression plasm ids and endogenous
Cyclin Bl was performed by incubating approximately lmg of lysate with 1.5 ug of
anti-Cyclin Bl (Sigma) at 4°C on a vertical rotator for overnight, then 70 uL of a 20
% protein G-Sepharose Slurry (GE Lifesciences) was added into immunocomplexes
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and for an hour at 4°C. When the incubation time was over, the tubes were
centrifuged, the supernatant was removed and the beads were washed in 500 uL of
TNT buffer three times. After the last supernatant was removed, 25 uL of 2 x SDS
sample buffer was added and the sample was boiled at 95°C for 5 minutes, and
subseuqntly run on an SDS-polyacrylamide gel (SDS-PAGE).

Western Blot Analysis
Post electrophoresis, gels were incubated in lx transfer buffer for 15 minutes at
room temperature on a shaker. At the same time, Immobilon-P membranes were
activated by methanol for 20 seconds and then equilibrated in lx transfer buffer for 10
minutes. The protein was transferred from the gel to the membrane using a semi-dry
apparatus (Biorad) at 9 volts for 35 minutes. After the transferring of the protein to the
membrane was completed, the membrane was blocked with Tris-buffered Saline and
Tween (TBST) containing 1% skin milk for at least 1 hour at room temperature in
order to reduce non-specific binding sites on the membrane. Then the membrane was
incubated with lug of the specified primary antibody in lOmL of TBST for one hour
at room temperature. The membrane was washed three times for 10 minutes with
TBST and subsequently incubated with the appropriate secondary antibody for
another 1 hour at room temperature. A dilution of 1:60,000 in TBST plus 1% skim
milk was used for the anti-mouse or anti-rabbit secondary antibodies which were
conjugated to horseradish peroxidase (HRP) (Amersham). Then, the membrane was
washed with lxTBST for 10 minutes and was incubated with Super Signal West
Femto Maximum Sensitivity Substrate (Pierce) dilution for five minutes and the
proteins of interest were visualized by chemiluminescense.
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Stripping and Reprobing of Western Blots
In order to detect additional proteins on the same blot, the membrane was
incubated with stripping buffer at 50°C for 30 minutes with some agitation and then
washed with lx TBST for 10 minutes at 50°C. The blot was then ready for re-use in
Western blot analysis.

Immunofluorescence
NIH 3T3 cells were seeded onto coverslips. 24 hours later, 3T3 cells were
transfected with GFP-Cyclin Bl and various hSak constructs using Effectene TM
(Qiagen) according to the manufacturer's recommendations. Approximately 16 hours
post-transfection, cells were washed twice with PBS, then fixed with 3.7%
paraformaldehyde in PBS pH 7.4 for 12 minutes at room temperature for 12 minutes,
and washed twice with PBS. Cells were then permeabilized with 0.1% Triton X-100
in PBS for 2 minutes at room temperature. Followed by washed again three times
with PBS and blocked by lx TBST containing 10% BSA for 30 minutes at 37°C. The
blocker was removed by washing the cover slips two times in TBST and then antiFlag antibody (Sigma) (1:1,000) was added to cells for 1 hour at room temperature
with incubation in the dark in a humid atmosphere. After washing three times with lx
TBST, 1:4000 Alexa-conjugated 568 nm goat anti-mouse secondary (Molecular
Probes) was added for 30 minutes, then washed three times with lx TBST and
incubated with 6'-diamidino-2-phenylindole (DAPI) (O.lmg/mL) (Molecular Probes)
for 5 minutes at room temperature, After washing the cells once with PBS, they were
fixed with a drop of mounting medium (Molecular Probes) and analyzed under a
fluorescence microscope.
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Expression and Purification of Baculovirus-expressed Protein
5xl0 6 SF9 insect cells were seeded in 10 cm tissue culture dishes. Cells were
allowed to settle and stick to the bottom of dishes 60 minutes, 20uL of recombinant
baculovirus encoding GST-Cyclin Blwas added (a kind gift from Dr.Helen PiwnicaWorms, Washington University School of Medicine) to 2mL Grace's media (Serum
free) and mixed gently. The media was removed from settled insect cells. 2mL virus
solution was added to the cells and rocked gently to disperse. The cells were
incubated at room temperature for 60 minutes. After 60 minutes, 8mL Grace's
complete media was added and incubated at 27°C for five days. Then the cells were
harvested by gently pipetting two times to suspend as many cells as possible, transfer
to sterile 15mL centrifuge tube and centrifuged at 2,500 rpm for 5 minutes. The cell
pellet was resuspended in 300uL ice-cold insect cell lysis buffer containing
reconstituted protease inhibitor cocktail. Cells were lysed on ice for 20 minutes.
Lysate was centrifuged at 13,000 x g for 20 minutes at 4°C. The clear supernatant was
added to Glutathione Sephrose Beads (GE) prepared according to manufacturer's
protocol. The purification was performed as previously described.

Cloning His-Gadd45a Construct
His-Gadd45a plasmid was cloned using Creator™ DNA Cloning Kits. It uses
Cre-loxP site to transfer Gadd45a from a Donor Vector plasmid to an Acceptor
Vector containing His-tag (Figure 4).
Firstly, the Creator reaction mixture was prepared as follows:
200 ng

Donor Vector

200 ng

Acceptor Vector

2 ul

1 OX Cre Reaction Buffer
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2 jil

10XBSA(lmg/ml)

1 ul

Cre Recombinase
Add deionized H20 to bring volume up to 20 u.1. Then the Creator reaction

mixture was incubated at room temperature (22-25°C) for 15 min and stopped by
heating tube at 70°C for 5 min. 1 ul of reaction mixture was transformed into
competent cells. Cells were grown at 37°C for 60 min in LB. 100 ul of transformation
was plated on a LB-agar plate containing 30ug/ml chloramphenicol, and 7% sucrose
(w/v) and Incubated overnight. The next day, the plate contained a mixture of larger
colonies and smaller colonies. Pick larger colonies for screening by colony PCR using
primers (PCP-1 and PCP-2) which only amplify across a recombination juncture. The
PCR reaction was set up as follows:
18.5 jil

PCR-Grade Water

2.5 JJJ

1 OX TITANIUM Taq PCR Buffer

1 ul

Creator Reaction Mixture

1 |il

PCP-1 Primer (10 uM)

1 Hi

PCP-2 Primer (10 uM)

0.5 ul

50X dNTP Mix (10 mM ea. of dATP, dCTP, dGTP, dTTP)

0.5 ul

50X TITANIUM Taq DNA Polymerase

25 ul

Total volume

Primer PCP-l: 5'-GCTCACCGTCTTTCATTGCC-3'
Primer PCP-2: 5'-TCCGCTCATGAGACAATAACC-3'
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Cre-lox recombination
Cm/Sucrose selection

Figure 4. Flow chart of Cloning His-Gadd45a construct using the Creator™
DNA Cloning System. The Creator System uses Cre-loxP site-specific recombination
to catalyze the transfer of a target gene Gadd45a from a Donor Vector plasmid to an
Acceptor Vector, a plasmid containing His-tag.
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Expression and Purification of His Fusion Proteins
E. coli BL21 cells were transformed with the His-Gadd45a plasmid. A single
transformed

colony was picked and inoculated in 200mL of LB medium

supplemented with 100 ug/mL of ampicilin and 34ug/mL chloramphenicol for
overnia ht at 37°C with vigorous shaking. The following day, the 100 mL starter
culture was added to 500 mL of LB medium and grown at 37°C until the OD6oo was
upon 0.6. Then expression was induced with 250 uL of 0.5 mM IPTG (Fisher). After
the cultures were grown for an additional 4 hours at 37°C, cells were harvested by
centrifugation at 10,000 x g for 30 minutes at 4°C. Cell pellets were resuspended in 20
mL cell lysis buffer and incubated for 20 minutes on ice, cells were then sonicated on
ice 10 times for 10 seconds until the cloudy cell suspension becomes translucent. The
lysate was centrifuged at 10,000 x g for 30 minutes at 4°C. The supernatant was added
to the HiTrap Chelating HP (Amershan Biosciences) and processed according to the
manufacturer's protocol. The flow rates were lmL/min to allow the protein to bind to
the column. Then the His elution buffer containing 5-50 mM imidazole were added to
column and the eluted protein was collected in lmL fractions. The fusion protein was
then seperated on 12% SDS-PAGE gel and visualized by both coomassie blue
staining and Western blot analysis.

In Vitro Kinase Assay
In order to determine whether CyclinBl is a substrate of Sak, an in vitro kinase
assay was performed. First, Flag-hSak, Flag-T170D and Flag-K41M expression
plasmids were transiently transfected into HEK-293 cells. The cells were lysed 24
hours post transfection and the cell lysate was incubated with 1 ug anti- Flag antibody
at 4 °C for 45 minutes. Then, 80uL of 20% protein G-sepharose slurry (GE
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Lifesciences) was added to each sample and incubated at 4 °C for 45 minutes. The
immunocomplexes were washed once with 500mM TNT wash buffer, once with
150mM TNT wash buffer, twice with 150mM TNT wash buffer containing 500mM
of LiCl and once with kinase buffer. The immnocomplexes were resuspended in 20
uL of kinase buffer, 2.5uL of cold ATP and 4ug of the GST-Cyclin Bl protein. The
kinase was started by the addition of lOuCi [y-32P] (Amersham Biosciences) and the
samples were then incubated at 30°C for 35 minutes. Following that, 6uL of 6x SDS
loading buffer was added to stop the reaction. Samples were boiled for 5 minutes and
then analyzed by SDS PAGE gel, then the gel was transferred to a PVDF membrane
as previously described. The membrane was then incubated overnight in the dark with
a phosphoimager in order to visualize phosphorylation band of protein. Following
this, the membrane was probed with an anti-Flag antibody in order to detect the
immunoprecipitated proteins. The sane blot was subsequently probed with an antiCyclin Bl antibody to confirm equal loading of the protein.

Preparation of Protein for Mass Spectroscopy
In order to extract the protein for mass spectroscropy, the coomassie stained
bands of interest were excised from the gel and placed in siliconized microtubes.
They were then incubated in 100 uL of destain solution and incubating for 35 minutes
at 37 °C, shaking at 225 RPM. This procedure was repeated twice, followed by
repeated changes of 100% acetonitrile to dehydrate the excised gel until it became
opaque. The pieces were then lyophilized by Speed Vac for 20 minutes to ensure that
the excised gel was completely dried.
The dehydrated bands were then rehydrated in trypsin digestion buffer
containing 13ng/uL promega modified trypsin and incubated on ice for 30 minutes.
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After this period, an addition 20 uL of 50 mM ammonium bicarbonate was added to
the gel pieces. Subsequently, the tubes were sealed with parafilm and incubated in a
shaker at 37 °C overnight. The following morning, the samples were briefly vortexed
and the remaining gel pieces spun down by centrifugation.

The supernatant

containing the extracted peptides was collected and transferred to a fresh siliconized
microtube containing 5 uL of 5% Formic Acid. In order to maximize the amount of
peptide extraction, 200 uL of 60 % acetonitrile and 1% Formic Acid were added to
the remaining gel pieces and allowed to incubate at 37 °C for 45 minutes. This step
was repeated an additional time. The gel pieces were then vortexed, spun down and
the supernatant was collected and added to the peptides collected and placed in the
siliconized microtubes. These pooled samples were then concentrated by subjecting
them to the Speed Vac until only 10 uL of supernatant remained. Then Zip-Tip
procedure was performed for desalting peptides. Firstly, the Zip-Tips (Eppendorf AG)
were equilibrated by aspirating 10 uL wetting solution (60% Acetonitrile in 1%
Formic Acid) into tips and dispensing to waste for 5 times, then peptides were bound
to Zip-Tip by aspirating and dispensing 20 cycles and 10 uL of washing solution (1%
Formic Acid) was aspirated and dispensed to waste for 10 times. 10 uL of elution
solution (60% Acetonitrile in 1% Formic Acid) was added into Eppendorf
microcentrifuge tube and aspirated and dispensed through Zip-Tip at least 20 times
without introducing air. Then, the desalted peptides were purified by using the
SigmaPrep. Spin Columns (Sigma). Firstly, 80 uL of the PHOS-Select affinity gel
(Sigma) was added into the column and washed by 500uL of wash / equilibration
buffer (250mM Acetic acid, 30% Acetonitrile) for 3 times. Followed by adding 100
uL sample (9 uL of trypsin digested peptides in 60% Acetonitrile, 1% Formic Acid
and 17.5M Acetic acid) into gel and the samples were incubated for 30 minutes at
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room temperature. The spin columns were placed in collection tubes which were
centrifuged at approximately 3000 rpm for 30 seconds, and then the resin was washed
by 500uL wash / equilibration buffer (250mM Acetic acid, 30% Acetonitrile) and
500uL of HPLC H 2 0. The peptides were first eluted by 100 uL of 400mM of
Ammomium Hydrotide, then eluted by lOOuL of 400mM of Acetic acid and 25%
Acetonitrile. Then Zip-Tip procedure was performed again for salt reduction which
may improve mass signals. luL of each sample was spotted directly on a MALD1
plate and subjected to mass spectroscopy.

UV Damage
In order to investigate the effect of DNA damage on Sak protein expression
levels, U2-OS and SaOS-2 cells plated in 100-mm dishes were rinsed with PBS and
irradiated with ultra-violet radiation using a Stratalink UV crosslinker (Stratagene) at
a dose of 10 mJ/cm2. After cell exposure to UV radiation, fresh medium was added in
plates, and the cells were cultured in the incubator and cells were collected at the
indicated times. Following lysis, Western blot analysis was performed.
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CHAPTER IV
RESULTS

Sak Interacts with Cyclin Bl
Based on the observation that Plkl phosphorylates Cyclin Bl and induces its
nuclear entry, we tested the possibility of an interaction between Sak and Cyclin Bl
by a co-immunoprecipitation (Co-IP) based approach. Specifically, HEK-293 cells
were transiently transfected with various Flag-tagged Sak constructs Flag-hSak (wildtype human Sak), Flag-hT170D (kinase active form of Sak), Flag-hK41M (kinase
dead form of Sak) and Flag-YVHl (a negative control) (Figure 6). 16 hours post
transfection, the expression of the Flag constructs were detected by Western blot
analysis with anti-Flag antibody (Figure 6A). Then, the co-ip was performed in which
anti-Cyclin Bl antibody was used to immunoprecipitate Cyclin Bl along with any
associated proteins. The presence of Flag-Sak fusion proteins in this complex was
determined with an anti-Flag antibody (Figure 6B). The results indicated that Sak
interacts with Cyclin Bl. Furthermore, this interaction was not dependent on Sak
kinase activity as both kinase dead and active forms of Sak also co-immunoprecitated
with Cyclin Bl. The control Flag tagged protein and Flag-YVHl was not detected,
thus indicating that the interaction was not via the Flag epitope.
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Kinase Domain
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Figure 5. Sak domain specific constructs. The figure representations Sak deletion
mutants and Sak kinase dead and kinase active mutants.

A

Lysates

Co-IP

IP: anti-CyclinBl
IB: anti-Flag

Figure 6. Sak interacts with Cyclin Bl. HEK-293 cells were transiently transfected
with various Flag-tagged Sak constructs, Flag-hSak (wild-type human Sak), FlaghT170D (kinase active form of Sak), Flag-hK41M (kinase dead form of Sak) and
Flag-YVHl (a negative control). (A) 16 hours post transfection, the expression of the
Flag constructs were detected by Western blot analysis with anti-Flag antibody and
followed by probing with an anti-GAPDH antibody to confirm equal protein loading.
(B) Co-ip was performed in which anti-Cyclin Bl antibody was used for
immunoprecipition with Sak and anti-Flag antibody for blotting the membrane.
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Co-localization ofSak and Cyclin Bl to the Centrosomes
To

further

confirm

the

interaction

of

Sak

and

Cyclin

Bl,

co-

iramunofluorescence analysis was performed. Cyclin Bl localizes to the cytoplasm
during S and G2 phases, From G2 to metaphase, part of Cyclin Bl is associated with
duplicating centrosomes (Hagting A et ah, 1998), a site which Sak is also localized
throughout the cell cycle. These observations prompted us to investigate whether Sak
co-localizes with Cyclin Bl in centrosome. In order to test this hypothesis, N1H 3T3
cells were seeded on cover slips, then fixed with paraformaldehyde and permeabilized
with Triton X-100. Followed by blocked by BSA. Then an anti-Flag antibody and
Alexa-conjugated 568 nm goat anti-mouse secondary was added to cells separately,
then cells were incubated with 6'-diamidino-2-phenylindole (DAPI) and analyzed
under a fluorescence microscope. The results confirmed that Sak co-localizes with
Cyclin Bl at the centrosomes (Figure 7).
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GHP-CyqlinBI

ElagJGllM

Figure 7. Sak co-localizes with Cyclin Bl at the centrosomes. NIH 3T3 cells were
transfected with GFP-Cyclin Bl (Green) and various hSak constructs for 16 hours.
The overexpressed kinase was detected with anti-Flag antibody (red). Cells were
stained with DAPI to detect the nucleus. (A, B) No co-localization showed up in two
negative controls. (C, D, E) Flag-Sak, Flag-T170D and Flag-K41M co-localized with
GFP-Cyclin Bl at the centrosomes, respectively.
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igure 8. Sak and Cyclin Bl mainly co-localize at centrosome. Histogram shows
the percentage of co-localization between GFP-Cyclin Bl and Various hSak
constructs at centrosome and nucleus. Data from three independent experiments,
counting 200 cells each; error bars indicate standard deviation.

Sak d&es not Phosphorylate Cyclin Bl In-Vitro
The interaction between Cyclin Bl and Sak suggested the possibility that
Cyclin Bl may be a substrate of Sak. To test this hypothesis, an in vitro kinase assay
was performed. Firstly the GST-Cyclin Bl fusion protein was purified for use as
substrate. To confirm the purity of the protein, SDS-PAGE was performed and the gel
was stained by coomassie blue (Figure 9A). Immunoblotting was performed using an
anti-Cyclin Bl antibody to further confirm the purity of the GST-Cyclin Bl protein.
Purified GST-Cyclin Bl protein yielded a protein of 85KDa, corresponding to the size
of the GST-Cyclin Bl protein (Figure 9B). Then HEK-293 cells were transiently
transfected with Flag-hSak, Flag-hT170D and Flag-hK41M using Effectene TM
(Qiagen). At 16 hours post transfection, the cells were lysed, the Flag fusion proteins
were immunoprecipitated by incubating 500ug of protein lysate with lug of anti-Flag
antibody.

The

kinase

assays

were

performed

as

follows;

individual

immunoprecipitated Flag-Sak proteins were incubated with baculovirus expressed
GST-Cyclin Bl in the presence of [y-32P] ATP (Amersham Biosciences). After 30
minutes of incubation, SDS-PAGE was performed and the membrane was exposed
using a phosphoimager (Perkin Elmer). In order to ensure that both substrate and Sak
protein were present, the membrane was also probed with an anti-Flag antibody and
anti-Cyclin Bl antibody. The results of these assays are shown in (Figure 9C-D). The
phosphorylated bands at lOOKDa correspond to the autophosphorylation of Flag-Sak
and Flag-T170D. Under these conditions, GST-Cyclin Bl was not phosphorylated by
Sak.
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Figure 9.

Western Blot

Sak does not Phosphorylate Cyclin Bl In-Vitro. (A) The GST-Cyclin

Bl protein was produced by infecting Sf9 insect cells with baculovirus encoding
GST-Cyclin Bl, and then purified it using GST beads, GST- Cyclin Bl protein was

analyzed by Coomassie blue-staining. Purified GST-Cyclin Bl protein yielded a
protein of 85KDa, corresponding to the size of the GST-Cyclin Bl protein. (B)
Western blot was also performed with anti-Cyclin B1 antibody to further confirm that
the band was GST-Cyclin Bl. (C) The purified GST-Cyclin Bl protein was incubated
with Flag-Sak in the presence of ATP, subjected to SDS-PAGE, transferred protein to
membrane and then visualized the bands using a phosphoimager. (D) The membrane
was then subjected to Western blot analysis with an anti-Cyclin Bl antibody to ensure
the equal GST- Cyclin B1 protein loading.
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Sak Interacts with Gadd45a
Gadd45a is a nuclear protein that is induced by genotoxic and other cellular
stresses. It has been demonstrated that Gadd45a plays important roles in growth
control, maintenance of genomic stability, DNA repair, cell cycle control and
apoptosis. Furthermore, deletion of Gadd45a leads to centrosome amplification and
abnormal mitosis and Gadd45a is found to interact with Aurora-A and BRCA1. Both
of proteins are located in centrosome, a site which Sak is also localized throughout the
cell cycle.
These observations prompted us to investigate whether Sak also interacts with
Gadd45a. To test this hypothesis, HEK-293 cells were transiently transfected with
domain specific expression plasmids for Flag tagged Sak (Figure 9). 16 hours post
transfection, the expression of the Flag constructs were detected by Western blot
analysis with anti-Flag antibody (Figure 10A). Then, co-immunoprecipitation of
endogenous Gadd45a and associated proteins was performed on cellular protein
extracts using an anti-Gadd45a antibody followed by Western Blotting using an antiFlag antibody (Figure 10B). The results indicated that Flag-Sak (full length), FlagT170D (kinase active), Flag-K41M (alternate kinase dead), Flag-154N (kinase dead),
Flag-APb (lacking polo-box domain), and Flag-Rl (cryptic polo-box domain) were all
associated with Gadd45a. Furthermore, we did not detect an interaction between FlagPb (polo-box domain) and Gadd45a indicating that the polo-box region of Sak was
not necessary or sufficient for this interaction to occur. These results establish that
Sak interacts with Gadd45a and the cryptic polo-box domain is sufficient for the
intercation.
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Figure 10. Sak interacts with Gadd45a. (A) HEK-293 cells were transiently
transfected with expression plasmids for Flag-Sak domain specific constructs. 16
hours post transfection cells were lysed. Whole cell lysates were immunoblotted with
an anti-Flag antibody to determine the levels of Flag-tagged proteins, followed by
probing with an anti-GAPDH antibody to confirm equal protein loading. (B)
Immunoprecipitation was performed using an anti-Gadd45a antibody on prepared
lysates and western blotting was performed using an anti-Flag antibody. Full length
Sak, kinase dead Sak (K41M), kinase active Sak (T170D), APb-Sak (deletion of polobox domain of Sak), an alternate kinase dead Sak (D154N) and cryptic-polo-box
domain (Rl) all co-immunoprecipitated with endogenous Gadd45a. The polo-box

domain (Pb) was not observed. Whole cell lysates of non-transfected cells and a
transfected construct encoding Flag-YVHI protein served as negative controls.
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Sak Phosphorylates Gadd45a In-Vitro
The interaction of Gadd45a and Sak suggested the possibility that Gadd45a
may be a substrate of Sak. Therefore, in vitro kinase assays was performed (Figure
11). First His-Gadd45a plasmid was cloned using Creator™ DNA Cloning Kits. To
test whether the plasmid is successful, a PCR was set up using primers (PCP-1 and
PCP-2) which only amplify across a recombination juncture. PCR band showed up at
350bp indicating that the plasmid may be successful (Figure 11A). Then the plasmid
was sequenced by ACGT corp and compared to wildtype Gadd45a, The result showed
that the plasmid is His-Gadd45a (Figure 1 IB). Then the His-Gadd45a fusion protein
was produced in bacteria using IPTG and purified using His affinity column. To
confirm the purity of the protein, SDS-PAGE was performed and the gel was stained
with coomassie blue (Figure 11C). Immunoblotting was performed using an antiGadd45a antibody to further confirm the purity of the His-Gadd45a protein. Purified
His-Gadd45a protein yielded a protein of 30KDa, corresponding to the size of the
His-Gadd45a protein (Figure 11D). In-vitro kinase assay was performed using the
purified His-fusion Gadd45a. HEK 293 cells were transfected with Flag-hSak, FlaghT170D and Flag-hK41M and immunoprecipitation was performed using an anti-Flag
antibody. The bacterially produced His-Gadd45a protein was incubated with the FlagSak immunoprecipitated constructs in the presence of [y-32P] ATP (Amersham
Biosciences), then SDS-PAGE was performed and membrane was exposed using a
phosphoimager (Perkin Elmer) (Figure HE). Subsequently, the membrane was
probed with an anti-Flag antibody and anti-Gadd45a antibody to confirm the equal
protein loading (Figure HE). The result showed that His-Gadd45a is phosphorylated
by wildtype Flag-Sak and kinase active Flag-T170D, but not phosphorlated by kinase
dead Flag-K41M. The phosphorylated bands at lOOKDa correspond to the
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autophosphorylation of wildtype Flag-Sak and kinase active Flag-T170D. The result
indicates that Gadd45a is a substrate of Sak.
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Figure 11. Sak Phosphorylates Gadd45a In-Vitro (A) His-Gadd45a construct was
cloned and A PCR was set up using primers (PCP-1 and PCP-2) to test His-Gadd45a
construct. PCR amplified product band showed up at 350bp. (B) The His-Gadd45a
plasmid was sequenced by ACGT corp and compared to wildtype Gadd45a. (C) HisGadd45a protein was expressed in bacteria using IPTG. The fusion protein was
purified using His affinity column and SDS PAGE was performed. Purification
resulted in a 30KDa band corresponding to His-Gadd45a protein at Coomassie bluestaining gel. (D) Western blot was also performed using an anti-Gadd45a antibody to
ensure the observed bands were His-Gadd45a protein. (E) Bacterially produced HisGadd45a was incubated with the Flag-Sak immunoprecipitated constructs in the
presence of [y-32P] ATP (Amersham Biosciences), then SDS-PAGE was performed
and membrane was exposed using a phosphoimager (Perkin Elmer). (F) The
membrane was subjected to Western blot analysis with an anti-Flag antibody to
ensure transfection efficiency, also using an anti-Gadd45a antibody to ensure equal
protein loading.
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Sak Phosphorylates TyrlSl on Gadd45a
In order to identify the phosphorylation site of Sak on Gadd45a, we employed
a mass spectrometry based approach in collaboration with the Vacratsis lab. An in
vitro cold kinase assay was performed, protein samples were separated by SDSPAGE gel, followed by coomassie blue staining (Figure 12A) and the particular
band(s) of interest were excised from the gel, and then digested with trypsin. The
extracted peptides were spotted directly on a MALDI plate and subjected to Mass
Spectroscopy. The Gadd45a phosphopeptide peak was identified by MALDI-TOF
mappings at 1840 m/z (Figure 12B) and the phosphorylation specific peptides of
Gadd45a are YMDQWVPVINLPER (Figure 12C). Then MALDI-PSD analysis of the
phosphorylation specific peptides was performed. The sequence of this peptide
enabled identification of the phosphorylated residue at Tyrl51 within Gadd45a
(Figure 12C). So, our preliminary results suggest that Sak phosphorylates Tyrl51 on
Gadd45a.
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Figure 12. Sak phosphorylates Tyrl51 on Gadd45a. (A) An in vitro cold kinase
assay was performed with the immunoprecipitated Flag-Sak protein, the purified HisGadd45a protein and cold ATP, protein samples were separated by SDS- PAGE gel,
followed by coomassie blue staining. (B) MALDI-TOF spectrum of His-Gadd45a
tryptic digest. Bacterially expressed His-Gadd45a was subjected to kinase assay with
Flag-Sak, expressed and immunoprecipitated from Hek 293T cells. The peak at 1307
m/z corresponds to Gadd45a peptide LGSFLDHSFGAR. The peak at 2212 m/z is
common trypsin proteolysis peak. The peaks at 1761 m/z and 1840 m/z are separated
by +80 Da, thus suggesting modification by phoshorylation. Phosphopeptide peak at
1840m/zis marked with asterisk and shifted by 80Da (HP03 = 80 Da) relative
to predicted unphosphorylated peptide peak

at

1761 m/z.

(C)

MALD1-PSD

spectrum of singly charged parental ion at 1840 m/z. The sequence of this peptide
enabled identification of the phosphorylated residue at Tyrl51 within Gadd45a.
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Downregulation ofSak Expression in Response to UV Irradiation is p53-dependent
Sak was identified as a p53 target gene (Swallow et al., 2005) and
transcriptionally repressed by p53. Furthermore, Sak mRNA levels decrease in
response to DNA damage in a p53-dependent manner (Li et al., 2005). So the
endogenous Sak protein expression levels in response to UV irradiation were
investigated in order to determine the effect of DNA damage on Sak protein
expression levels. U2-OS and SaOS-2 cells were irradiated with ultra-violet radiation,
then collected at the indicated time. The Sak protein levels were quantified by
Western blotting analysis.
The results showed that endogenous Sak expression was significantly repressed in
response to UV damage in U2-OS cells (wildtype p53) (Figure 13), whereas no
significant change in Sak protein expression was observed in SaOS-2 cells (p53-null)
(Figure 14). The results suggested that downregulation of Sak expression in response
to UV irradiation is p53-dependent.
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Figure 13. UV radiation decreases Sak protein expression levels in the U2-OS
cells. (A) The U2-OS cells were exposed to UV irradiation and lysed at the indicated
time points. The endogenous Sak protein expression levels were quantified by
Western blotting analysis with anti-Sak antibody. Lysate were probed with an antiGAPDH antibody as a loading control. (B) Compared to no UV damage, the
endogenous Sak protein expression levels have no change at 5 and 30 minutes after
UV damage, but Sak expression levels decrease after 1 hour.
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Figure 14. The endogenous Sak protein expression levels remain constant in
SaOS-2 cells. (A) The SaOS-2 cells were exposed to UV irradiation and lysed at
indicated time points. The endogenous Sak protein expression levels were quantified
by Western blotting analysis with anti-Sak antibody. Lysate were probed with an antiGAPDH antibody as a loading control. (B) Compared to no UV damage, the
endogenous Sak protein expression levels remain constant in SaOS-2 cells after UV
damage at indicated time points.
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CHAPTER V
DISCUSSION

Sak interacting partners
Plks are a conserved subfamily of Ser/Thr protein kinases that play pivotal
roles in regulating various cellular and biochemical events at multiple stages of cell
cycle progression (Glover et al., 1998; Nigg, 1998; Dai et al., 2003). They regulate
cell cycle progression, including centrosome duplication, DNA damage response,
Golgi dynamics, mitotic entry, spindle assembly and cytokinesis.
Sak was the last member of the human Plk family to be identified. Sak has
been implicated in playing a role in centriole biogenesis (Habedanck R et al., 2005)
and has been implicated in playing a role during mitosis (Fode et al. 2004; Hudson et
al. 2001). Both Sak levels and localization change throughout the cell cycle with Sak
mRNA levels relatively low in both GO and early-to-mid-Gl phase cells, an increase
in S and G2 and peaking in M phase. Sak homozygous null mice are embryonic
lethal at E7.5 with a marked increase in mitotic and apoptotic cells (Hudson et al
2001) and Sak haploinsufficiency causes mitotic infidelity and carcinogenesis (Ko et
al, 2005). Sak heterozygous mice are fertile. However at age 18-24 months Sak
heterozygous mice have an increased incidence of developing liver and lung cancers
when compared to wild-type mice. While there is an increasing body of evidence for
phenotypes associated with Sak function, the exact functions or specifically its
molecular targets remain largely unknown. The purpose of my research was to
identify/characterize Sak's interaction with several key cellular proteins with the goal
of helping us further understand the essential role of Sak in the cell cycle.
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The interaction between Sak and Cyclin Bl
Previous studies have found that Plkl interacts with and phosphorylates
Cyclin Bl thus inducing Cyclin B l ' s nuclear entry (Toyoshima-Morimoto F et al.,
2001). This is proposed to be essential for the induction and coordination of the
initiation of mitosis (Toyoshima-Morimoto et al, 2001). Similar to Sak, Cyclin Bl
localization changes during the cell cycle. The protein is in the cytoplasm during S
and G2 phases where a subpopulation associates with microtubules. Cyclin Bl
accumulation in the cytoplasm up to metaphase upon which time it translocates to the
nuclems. Furthermore a subpopulation of the protein associated with duplicating
centrosomes (Hagting A et al, 1998), a site which Sak is also localized to. These
observations prompted us to investigate whether Sak also interacts with Cyclin Bl.
Interestingly through co-immunoprecipition and co-localization experiments, we
found that Sak both physically interacts with Cyclin Bl and co-localizes with it at the
centrosome. Cyclin Bl is a protein that binds to CDK1 to form a complex called MPF
(mitosis promoting factor), MPF is activated by phosphatase Cdc25C in M phase, and
then triggers mitosis. So Cyclin Bl is a necessary protein for mitosis entry. The
finding suggests that Sak may play a novel role in mitosis entry through binding
Cyclin Bl.
The interaction of Sak with Cyclin Bl suggests that Cyclin Bl may be a
substrate of Sak. This is supported by a recent study by Leung et al 2006 in which a
putative phosphorylation target motif for Sak substrates was proposed to be
[IFYLW]-{ILV}-[ST]-[YVFLICA]-[YVFLICA]-X-[PIFYLW]

(Leung GC et

al,

2006). Using Expasy software, we found that the Cyclin Bl protein includes a match
for the consensus phosphorylation site of Sak substrates. However, after numerous invitro kinase assays, we were unable to demonstrate the Sak phosphorylates Cyclin Bl.

73

There are several possible explanations for our inability to observe Cyclin Bl
phosphorylation. The simplest is that my observations are correct and Cyclin Bl is not
a substrate of Sak. The possibility is that the observed association serves to place key
proteins including Sak in close proximity. For example, Cdc25C is a phosphatase
which can activate the Cyclin B/Cdkl complex by dephosphorylation of Cdkl at
Thrl4 and Tyrl5 at end of G2 phase, thus triggering G2/M transition. This association
may require the presence of Cyclin Bl in order to place Sak, Cdc25C and possibly
other proteins together. Like Sak and CyclinBl, Cdc25C is also localized to
centrosomes (Busch C et al, 2007). In this scenario the centrosome may function as a
site of integration for the proteins that trigger mitosis.
Another possible explanation is that Sak may phosphorylate Cyclin Bl under
some special condition, for example genotoxic or DNA damage. Sak has been found
to phosphorylate Chk2 in vitro, however the phosphorylation of Chk2 by Sak is
abolished in response to UV (S. Petrinac, MSc thesis, 2007), which suggests DNA
damage can alter the activity of Sak. Therefore, it will be interest to determine
whether Cyclin Bl is phosphorylated by Sak in response to UV radiation or some
other genotoxic stress. Still another alternative scenario is that, Sak may require the
presence of other proteins, which together form a complex that regulates Sak activity
towards Cyclin Bl. Their functions may include changing the conformation of the
Sak protein or possibly the substrate Cyclin Bl itself in a manner that exposes the
targeted residues.

Sak interacts with andphosphorylates Gadd45a
Gadd45a, growth arrest- and DNA damage inducible gene, is involved in
control of centrosome duplication and maintenance of genomic stability. Deletion of
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Gadd45a leads to centrosome amplification, abnormal mitosis and aneupioidy.
Furthermore, Gadd45a is found to physically interact with Aurora-A and BRCA1
(Shao SJ et al, 2006) that also localize to the centrosome. These observations
prompted us to investigate a possible interaction between Sak and Gadd45a. In order
to test this hypothesis, a co-immunoprecipitation experiment was performed using an
anti-Gadd45a antibody followed by Western blotting using an anti-Flag antibody. The
results indicated that wild type, kinase active and kinase dead forms of Flag-Sak all
associated with Gadd45a. We found no association between the Sak polo-box domain
and Gadd45a. The polo-box regions of Plkl-3

have been

implicated

as

phosphopeptide substrate binding motifs that play a role in both substrate recognition
and localization of these proteins (Lowery DW et al, 2004J. A truncated Sak protein
that lacked the polo box was still able to associate with Gadd45a. Interestingly, the
cryptic polo box region, Rl was sufficient for the interaction.
The interaction between Gadd45a and Sak suggested the possibility that
Gadd45a may be a substrate of Sak. Therefore, we tested the ability of Sak to
phosphorylate bacterially expressed and affinity purified His-Gadd45a fusion protein
using an in vitro kinase assay assay. The results demonstrate that Gadd45a is a
substrate of Sak as both wild type and kinase active forms of Sak were able to
phosphorylate Gadd45a. Our results are also consistent with the finding that the polobox domain of Sak may not function as a substrate docking site (Lowery DW et al,
2005). The possibility exits that the cryptic polobox may fulfill this function. Future
experiments would be necessary to determine this possibility.

Implications of the interaction of Sak and Gadd45a
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Gadd45a is nuclear protein that is induced by genotoxic and certain other
cellular stresses, including UV radiation, methyl methanesulfonate, and ionizing
radiation. It is involved in growth control, maintenance of genomic stability, DNA
repair, cell cycle control, and apoptosis. A previous study found that mouse
embryonic fibroblasts derived from Gadd45a knock-out mice exhibit centrosome
amplification and abnormal cytokinesis (Hollander M C et al., 1999), suggesting that
Gadd45a may play a critical role in the maintenance of centrosome stability. Gadd45a
is also found to be transcriptionally activated by p53 (Kastan MB et al, 1992), which
has been implicated in the maintenance of genomic stability and regulation of
centrosome duplication. Furthermore, Gadd45a was demonstrated to interact with
Aurora-A, strongly inhibit its kinase activity and antagonize Aurora-A-induced
centrosome amplification (Shao SJ et al., 2006). Sak is also involved in maintenance
of centrosome stability. Both gain- and loss-of-function experiments demonstrate that
Sak is required for the precise reproduction of centrosomes during the cell cycle.
However, the exact mechanism of how Sak play the role in centrosome duplication
remains unclear. Our finding that Sak phosphorylates Gadd45a provides a novel
mechanism that Sak might regulate centrosome stability probably via its effect on
Gadd45a activity. Further studies are required to elucidate the relationship between
Sak and Gadd45a in centrosome duplication in more detail. A broader understanding
of Sak- regulated signaling pathways in maintaining centrosome stability and genomic
fidelity will be invaluable.

Sak phosphorylates TyrlSl on Gadd45a
Protein phosphorylation plays a vital role in the cellular processes. Many
signaling

transduction

pathways

were
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formed

by

phosphorylation

and

dephosphorylation. Phosphorylation usually occurs on serine, threonine, and tyrosine
residues in eukaryotic proteins and phosphorylation of any site can change a protein'
stability, activity and cellular localization. Therefore, characterizing the putative
targets of Sak on Gadd45a will be useful in shedding light on Sak function.
Like many other kinases, the polo-like kinase family is also regulated by
phosphorylation. The four mammalian family members share overlapping functions,
with some overlap in target proteins and the residues targeted. Additionally, they also
phosphorylate unique residues within common substrates as well as unique substrates.
Recently, Johnson et al identified the predominant consensus sequence from the set of
substrates identified for each Plk member. The results indicate the consensus substrate
sequences for Sak include a basic residue at -3 (37%), an acidic residue at -2 (50%),
Tyr or hydrophobic {V) at +1 (47%) and +2 (89%), and Ser/Thr (42%) or Ala (26%)
at +4. While this motif like that of leung et al, 2007 also predicts phosphorylation of
Cyclin Bl, which we didn't observe, it does not predict that Gadd45a as a potential
substrate. The interaction of Sak and Gadd45a prompted us to attempt to determine
the phosphorylation site of Sak on Gadd45a. Using and in vitro kinase assay and a
mass spectrometry based approach, the preliminary results suggested that the specific
phosphorylation peptides for Gadd45a is Tyrl51 within the following peptide
YMDQWVPVINLPER

(see

Figurel2C).

Sak

kinase

domain

resembles

a

serine/threonine kinase. However, the active site loop of Sak more closely resembles
that of a tyrosine kinase. Therefore the possibility exists that Sak is a dual specificity
kinase be able to phosphorylate Ser/Thr and Tyr.

Sak expression levels decrease after UV irradiation
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Plks regulate multiple processes in normal cell cycle progression and play key
roles in DNA damage checkpoint pathways. Extensive research has demonstrated that
Plks are important mediators for various cell cycle checkpoints that monitor
centrosome duplication, DNA replication, formation of bipolar mitotic spindle,
segregation of chromosomes, and mitotic exit, thus protecting cells against genetic
instability during cell division (Nigg, 1998; Dai et al., 2002; Barr et al., 2004). Plkl
expression level is inhibited in response to DNA damage. The DNA damage-induced
inhibition of Plkl appears to be mediated by blocking its activation because
expression of activation mutants of Plkl can override the G2/M arrest induced by
DNA damage (Smits et al., 2000). In addition, Plkl can phosphorylate and inactivate
p53, the inhibition of Plkl in response to DNA damage leads to the activation of p53
which plays an important role in maintaining genomic fidelity by controlling cell
cycle checkpoints and apoptotic process following cell exposure to genotoxic stress
(Levine, 1997). In response to DNA damage, Plk2 and Plk3 are activated, suggesting
that Plks have different roles in checkpoint control (Xie et al., 2001). Furthermore,
Plk3 also physically phosphorylates and activates p53 during DNA damage, thus the
activation of Plk3 in response to DNA damage leads to the activation of p53 (Ando et
al., 2004). Sak has also been implicated in DNA damage response pathways. Sak was
identified as a p53 target gene (Swallow et al., 2005) and transcriptionally repressed
by p53. Furthermore, Sak mRNA levels decrease in response to DNA damage in a
p53-dependent manner (Li et al., 2005). Since Sak levels, as well as its relationship
with its interacting partners, may be effected by DNA damage, we were interested in
examining the effect of UV irradiation on endogenous Sak protein expression levels.
Commercial antibodies that recognize endogenous Sak protein have only recently
become available. Sak protein expression was significantly repressed in response to
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UV irradiation in p53-wildtype U2-OS cells, consistent with the decrease of Sak
mRNA levels in response to DNA damage. To further demonstrate that this was a p53
mediated event we also tested Sak protein levels after UV irradiation of a p53 null cell
line, SaOS-2. SaOS-2 cells were derived from a human osteogenic sarcoma. As
expected, no significant change in Sak expression level was observed in SaOS-2 cells.
Taken together, the results strongly suggested that downregulation of Sak expression
is p53-dependent.
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Appendix A: Solutions
Competent Cell Solutions
TFBI
30mM KOAc
50mM MnC12
lOOmMKCl
10mMCaC12
7% glycerol

TFBII
lOmM MOPS pH 7.0
75mM CaC12
lOmMKCl
7% glycerol

TYM broth
2% bactotryptone
0.5% yeast extract
O.lMNaCl
10mMMgSO4

Transformation

LB Media(lL)
lOg tryptone
5g yeast extract
lOgNaCl
Adjust pH to 7.0 and autoclave

LB-AMP Plates (1L)
1 Og tryptone
5g yeast extract
lOgNaCl
80

15gAgar
Autoclave.
After the solution has cooled, ampicilin was added to a final concentration of 100
ug/ml.

Cell Culture

Cell Media
500mL Dulbecco's Modified Eagle's Medium (DMEM)
50 mL(10%) Fetal Bovine Serum
5mL (1%) Penicillin/Streptomycin
5mL (1%) Amphotericin B
500 uL Gentamycin

500mL Grace' Insect Medium
50mL(10%) Insect Medium Supplement 10X
5mL (1%) Penicillin/Streptomycin

Cell Lysis

PBS
4.3mM Na 2 HP0 4
1.4mMKH 2 P0 4
137mM NaCl
2.7mM KC1
pH to 7.4

Lysis Buffer
50mM Tris-HCl pH 7.4
150mMNaCl
ImMEDTA
1% Triton X-100
1 protease inhibitor tablet (Roche) was added to every lOmL of buffer
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Western Blotting

Tris Buffer Saline(TBS)
100mMTris-ClpH7.4
150mMNaCl

TNT
0.1% Triton X-100
50 mMTris-HCl pH 7.4
150mMNaCl

6 X SDS-PAGE sample buffer (lOmL)
1M Tris pH 7.5
3.0mL 100% glycerol
lgSDS
lOOmg bromophenol blue
Ultrapture water was added to a final volume of 10 mL

Running Buffer
25mM Tris
250mM Glycine
0.1% SDS

Transfer Buffer
3.03g Tris base
14.4g glycine
2000mL methanol

IX TEST (Tris buffered saline and Tween)
100mMTris-ClpH7.5
150mMNaCl
0.1% Tween

Stripping Buffer
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lOmL 10%(w/v) SDS
6.25mL 0.5M Tris-HCl (pH=6.7)
342ul Beta-Mercaptoethanol
Filled to 50 mL with ddH20

Fix Solution

Coomassie Blue Stain
0.2%(w/v) Coomassie Blue
7.5% Glacial Acetic Acid
50% Ethanol

Destain Solution
0.75%Glacial Acetic Acid
10% Ethanol

Immunofluorescence

3.7% Paraformaldehyde
3.7g paraformaldehyde
70ml ddH20
lOmL 10XPBS
Adjust pH 7.0
Add ddH20 to lOOmL and filter though 0.45u filter

GST- Protein Purification buffers

Cell Lysis Buffer
50 mM Tris pH 7.5
lOOmMNaCl
O.lmMEDTA
0.1% Triton X-100
2mMDTT
1 protease inhibitor tablet (Roche) per lOmL buffer
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Elution Buffer
lOOmMNaCl
50mMTris pH 8.0
lOmM Glutathione

His- Protein Purification buffers
Start Buffer
5mM Imidazole
lOOmMNaCl
50mM Tris pH7.5

Kinase Buffer
60mM HEPES pH 7.5
3mM MgC12
3mM MnC12
50mMNaF
12mMDTT
1 protease inhibitor tablet (Roche) per lOmL buffer
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